Weight Management

>

Latest News

Pfizer Advances Oral GLP-1 Development as the Race for Second-Gen Obesity Therapies Continues
Pfizer Advances Oral GLP-1 Development as the Race for Second-Gen Obesity Therapies Continues

July 12th 2024

Pfizer joins Eli Lilly and Novo Nordisk in the development of oral GLP-1 receptor agonist candidates.

Head to Head Comparison of GLP-1 RAs for Weight Loss Tips Scales in Tirzepatide’s Favor
Head to Head Comparison of GLP-1 RAs for Weight Loss Tips Scales in Tirzepatide’s Favor

July 9th 2024

© 2024 MJH Life Sciences

All rights reserved.